Genmab A/S (GNMSF) Stock Chart & Stock Price History $274.50 +15.00 (+5.78%) As of 09/5/2025 03:41 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Genmab A/S Stock Price Performance The Genmab A/S (GNMSF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1.08%, with a year-to-date return of 32.37%. In the past month, the stock has increased 26.90%, reflecting recent market activity. As of the latest close, Genmab A/S traded at $274.50 with a market cap of $18.14 billion and volume of 3,921 shares. Five years ago, the stock traded at $347.11, representing a 20.92% decrease over that period. At the time, it had a market cap of $23.14 billion and a volume of 238 shares. Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+10.13%1 Month Performance+26.90%3 Month Performance+25.85%Year-To-Date Performance+32.37%1 Year Performance+1.08%5 Year Performance-20.92% GNMSF Stock Chart for Saturday, September, 6, 2025 GNMSF Chart by TradingView Genmab A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/05/2025$259.50$274.50+5.78%$274.50$274.503,921 shs$18.14 billion09/04/2025$259.50$259.50$259.50$259.505 shs$17.15 billion09/03/2025$249.25$259.50+4.11%$259.50$259.505 shs$17.15 billion09/02/2025$249.25$249.25$249.25$249.25131 shs$16.47 billion09/01/2025$249.25$249.25$249.25$249.25131 shs$16.47 billion08/29/2025$248.50$249.25+0.30%$249.25$249.25131 shs$16.47 billion08/28/2025$241.84$248.50+2.75%$248.50$248.505 shs$16.42 billion08/27/2025$241.84$241.84$241.84$241.844 shs$15.98 billion08/26/2025$245.00$241.84-1.29%$241.84$241.844 shs$15.98 billion08/25/2025$244.35$245.00+0.27%$245.00$245.0032 shs$16.19 billion Get the Latest News and Ratings for GNMSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 08/22/2025$244.35$244.35$244.44$244.35266 shs$16.15 billion08/21/2025$240.98$244.35+1.40%$244.44$244.35266 shs$16.14 billion08/20/2025$232.30$240.98+3.74%$240.98$232.80507 shs$15.92 billion08/18/2025$232.30$232.30$232.30$232.3025 shs$15.35 billion08/15/2025$216.31$232.30+7.39%$232.30$232.3025 shs$15.35 billion08/14/2025$216.31$216.31$216.31$216.31100 shs$14.29 billion08/13/2025$216.31$216.31$216.31$216.31100 shs$14.29 billion08/12/2025$216.31$216.31$216.31$216.3110,000 shs$14.29 billion08/11/2025$216.31$216.31$216.31$216.3110,000 shs$14.29 billion08/07/2025$216.31$216.31$216.31$216.314 shs$14.29 billion08/06/2025$222.50$216.31-2.78%$216.31$216.314 shs$14.29 billion08/05/2025$222.50$222.50$223.00$222.5010 shs$14.70 billion Related Companies Takeda Pharmaceutical Stock Chart Daiichi Sankyo Stock Chart argenex Stock Chart BeOne Medicines Stock Chart Insmed Stock Chart BioNTech Stock Chart Teva Pharmaceutical Industries Stock Chart Summit Therapeutics Stock Chart Genmab A/S Stock Chart Ascendis Pharma A/S Stock Chart Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GNMSF) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredOdd “310F trade” doubles investor’s money in just 3 days?Have you heard of 310F? This unusual trade setup has quietly delivered one of the most consistent profit st...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNMSF Stock Alerts